Filing Details

Accession Number:
0001140361-18-030011
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-26 20:31:30
Reporting Period:
2018-06-22
Accepted Time:
2018-06-26 20:31:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1238403 K Daniel Spiegelman C/O Biomarin Pharmaceutical Inc.,
770 Lindaro St.
San Rafael CA 94901
Evp, Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-06-22 9,528 $99.00 51,542 No 4 S Direct
Common Stock Disposition 2018-06-22 472 $99.01 51,070 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Trade made pursuant to a 10b5-1 plan executed on August 15, 2017.